ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 939 filers reported holding ASTRAZENECA PLC in Q4 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $382,941 | -5.4% | 5,655 | 0.0% | 0.07% | +1.5% |
Q2 2023 | $404,759 | +7.6% | 5,655 | +4.4% | 0.07% | -5.6% |
Q1 2023 | $376,162 | +1.9% | 5,419 | -0.5% | 0.07% | -7.7% |
Q4 2022 | $369,154 | +2.5% | 5,445 | -17.2% | 0.08% | -3.7% |
Q3 2022 | $360,000 | -17.2% | 6,573 | -0.1% | 0.08% | -4.7% |
Q2 2022 | $435,000 | -0.2% | 6,577 | 0.0% | 0.08% | +19.7% |
Q1 2022 | $436,000 | +13.8% | 6,577 | +0.0% | 0.07% | +14.5% |
Q4 2021 | $383,000 | -45.5% | 6,576 | -43.8% | 0.06% | -49.6% |
Q3 2021 | $703,000 | +3.5% | 11,701 | +3.2% | 0.12% | +3.4% |
Q2 2021 | $679,000 | +18.7% | 11,337 | -1.4% | 0.12% | +9.2% |
Q1 2021 | $572,000 | -1.4% | 11,496 | -0.9% | 0.11% | -5.2% |
Q4 2020 | $580,000 | -3.5% | 11,600 | +5.8% | 0.12% | -16.1% |
Q3 2020 | $601,000 | +153.6% | 10,960 | +144.8% | 0.14% | +136.2% |
Q2 2020 | $237,000 | -4.4% | 4,478 | -25.5% | 0.06% | +5.5% |
Q2 2019 | $248,000 | -22.7% | 6,012 | -29.0% | 0.06% | -58.3% |
Q4 2018 | $321,000 | – | 8,468 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 611,665 | $35,629,000 | 8.68% |
SPHERA FUNDS MANAGEMENT LTD. | 1,055,467 | $61,481,000 | 6.76% |
Endurant Capital Management LP | 324,728 | $18,915,000 | 4.57% |
Darwin Global Management, Ltd. | 511,908 | $29,819,000 | 4.56% |
SAL Trading, LLC | 188,276 | $10,967,000 | 4.47% |
Susquehanna International Securities, Ltd. | 126,356 | $7,360,000 | 4.45% |
ARDSLEY ADVISORY PARTNERS LP | 400,000 | $23,300,000 | 4.44% |
Avidity Partners Management LP | 2,867,200 | $167,014,000 | 3.54% |
Eversept Partners, LP | 949,224 | $55,292,298 | 3.53% |
GQG Partners LLC | 19,453,752 | $1,132,984,000 | 2.81% |